Nearly 12 percent of Americans, roughly 40 million, have used a GLP-1 for weight loss, including about one-fifth of women ages 50 to 64, a recent RAND report finds
Who is it for: Zepbound (tirzepatide) is recommended for pre-, peri- and post-menopausal women who qualify for weight loss treatments and would benefit from a holistic platform with 24/7 access to physicians and a supportive community of experts and other women in this life stage
Although prophylactic antibiotic therapy can provide temporary protection, it is counterbalanced by the risk of accelerating antimicrobial resistance
MT-1 is a linear peptide that selectively activates the MC1R receptor the primary switch for melanin production
By comparison, people taking a placebo lost only 2.6% of their body weight on average
It's a common synthetic antioxidant that's used as a preservative